Search Results - "M. Cremante"

Feasibility of stereotactic radiotherapy with pembrolizumab in patients with deficient mismatch repair/microsatellite unstable metastatic colorectal cancer by A. Gandini, V. Martelli, L. Belgioia, S. Puglisi, M. Cremante, V. Murianni, A. Damassi, C. Pirrone, F. Catalano, M. Grassi, L. Trevisan, S. Vagge, V. Andretta, S. Mammoliti, D. Comandini, G. Fornarini, A. Pessino, A. Pastorino, S. Sciallero, A. Puccini, A.F. Sobrero

“…Background: Patients with metastatic colorectal cancer (mCRC) carrying a deficit in the mismatch repair system/microsatellite instability (dMMR/MSI) show great…”
Get full text

1305P Landscape and clinical significance of germline pathogenic variants (PV) in pancreatic cancer (PC)-predisposing genes in PC patients by Gandini, A., Pastorino, L., Ponzano, M., Puglisi, S., Borea, R., Cremante, M., Grassi, M., Bruno, W., Dalmasso, B., Andreotti, V., Vanni, I., Allavena, E., Catalano, F., Martelli, V., Pastorino, A., Iaia, M.L., Fornarini, G., Sciallero, M.S., Puccini, A., Ghiorzo, P.

Get full text

597P Endometrial carcinoma and mismatch repair deficiency: Clinical association and universal screening for Lynch syndrome by Puglisi, S., Ponzano, M., Perachino, M., Pirrone, C., Damassi, A., Bregni, G., Puccini, A., Grassi, M., Trevisan, L., Gismondi, V., Dono, M., Lastraioli, S., Fedele, P., Cremante, M., Gandini, A., Giannelli, F., Mammoliti, S., Vellone, V.G., Sciallero, M.S., Iaia, M.L.

Get full text

1476P Immunohistochemical (mIHC) analyses of the immune tumor microenvironment (I-TME) in metastatic renal cell carcinoma (mRCC) patients (pts) receiving immunotherapy: Main results from the Meet-URO 18 study by Rebuzzi, S.E., Rescigno, P., Signori, A., Brunelli, M., Galuppini, F., Vellone, V.G., Gaggero, G., Maruzzo, M., Milella, M., Vignani, F., Cavo, A., Basso, U., Catalano, F., Murianni, V., Cremante, M., Damassi, A., Llaja Obispo, M.A., Banna, G.L., Buti, S., Fornarini, G.

Get full text

445TiP VIVA trial: A randomized phase II study of adjuvant regorafenib plus durvalumab in stage IV colorectal cancer patients achieving the no evidence of disease state by Pastorino, A., Puccini, A., Martelli, V., Grassi, M., Cremante, M., Gandini, A., Puglisi, S., Catalano, F., Murianni, V., Pessino, A., Andretta, V., Mammoliti, S., Sciallero, M.S., Comandini, D., Fornarini, G., Caprioni, F., Bregni, G., Barni, S., Labianca, R., Sobrero, A.F.

Get full text

56P Pembrolizumab in advanced mesenchymal tumors: A prospective monocentric study by Cremante, M., Catalano, F., Comandini, D., Mascherini, M., Zaottini, F., Picasso, R., Spina, B., Guadagno, A., Grassi, M.

Get full text